Pricing database updated August 4, 2026Methodology v1.0How we score →
Compare Providers
Home / Provider scoring methodology
Written by Dr. Parmis Mojarab, DO·Published July 12, 2026·Last reviewed August 4, 2026·Methodology v1.0
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.

Provider scoring methodology

The detailed scoring rubric for telehealth providers, including points available per criterion and the missing-information rule.

Category detail

Each of the six categories in our methodology breaks into named criteria with points available and points awarded. Clinical safety (25 points) covers licensed review, eligibility screening, follow-up access, laboratory process, adverse-event handling, emergency limitations and clear contraindications. Pharmacy (20 points) covers pharmacy identification, independent license verification, 503A/503B accuracy, disclosed concentration and formulation, and the absence of misleading FDA-approval claims.

Missing-information rule

A provider does not receive full points when material information cannot be verified. We record each fact as Verified, Partially verified, Provider-reported, Not disclosed, Contradicted or Outdated.

How the dates on this page work. Manufacturer self-pay prices — NovoCare and LillyDirect — were re-read on the manufacturers’ own published price guides on 4 August 2026. Figures captured from third-party provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row says so. We do not restamp a figure we have not re-read.